Democritus University of Thrace (DUTH)
Η σχέση ομοκυστεΐνης με την εμφάνιση της εν τω βάθει φλεβοθρόμβωσης σε ασθενείς με αρθροπλαστική γόνατος ή ισχίου
Abstract
dc:descriptionIntroduction: Some patients might have a genetic or serologic predisposition that may interact with environmental factors that lead to thromboembolic disease. If these patients could be identified preoperatively, they could be targeted for pharmacologic intervention, sparing many low risk patients from pharmaceutic prophylaxis, redusing the cost and appearance of complications from these products. Objectives: We performed this study in order to determine the relationship between hyperhomocysteinemia and postoperative thromboembolic events in patients undergoing total hip athroplasty or total knee arthroplasty.Materials – Methods: Between September 2004 and June 2006, 204 patients underwent primary THA or TKA in two orthopaedic departments. 31 were excluded from the study, the criteria for exclusion being a history of DVT or PE (4 patients ), ongoing anticoagulation therapy ( 11 patients ), previous operation in the same leg (14 ) patients, kidney disease ( creatinine >2 ) (2 patients ). One patient also excluded from the study because of a periprothetic fracture 16 days after THA. We studied 172 patients ( 41 male and 131 female ) with mean age 70,2 years (48 -85 ). We performed 99 TKA and 73 THA operations. Total plasma homocysteine as well as other thrombophilic agents (protein C, protein S, Antithrombin III , Lupus anticoagulants, APC-Resistance) were measured preoperatively. The type of anesthesia was combined spinal and epidural. Our patients divided in two groups according to preoperative screening. One group included patients with normal homocysteine level (less than 15μmole/L ) and in the second group included patients with elevated homocysteine levels (more than 15μmole/L ). In all of these patients we administered prophylactic anticoagulant therapy, in the form of Calcium Nordoparine, for six weeks postoperatively. Specifically we administered 2850 anti-xa (0,3ml) 12 hours before the operation. On the third postoperative day, the dosage was increased to 5700 anti-xa ( 0,6ml ) and remained the same until the end of the treatment.The diagnosis of DVT was established on clinical grounds and on colour Doppler exam of the lower extremities. The diagnosis of PE was based on Spiral CT findings. All patients were submitted in Duplex sonography which was performed twice postoperatively, the first on the 7th day (+/-2) and the other on the 42th day (+/- 2). Patient follow-up was of 6 weeks. Results: Out of 172 patents 45 had high levels of total plasma homocysteine ( 26,12% ) . Specifically 41 patients had mild hyperhomocysteinemia ( 15 – 30μmole/L ) and 4 had moderate hyperhomocysteinemia ( 30 – 100μmole/L) .Regarding the occurrence of thrombotic events in the group with elevated homocysteine levels only 1 patient developed deep venous thrombosis . In the group with normal homocysteine levels occurred 3 thrombotic episodes, of which 2 were in the form of non-fatal pulmonary embolism.Conclusions: These results indicate that the incidence of deep venous thrombosis in both populations, with normal and elevated homocysteine levels, show no statistically significant difference. Therefore, in patients undergoing total hip or knee arthroplasty and receiving prophylactic antithrombotic therapy LMWH, preoperative screening for homocysteine levels in the blood is not recommended. It is worth noting a different reading of the results but taking into account the small sample size. If we deal only with moderate hyperhomocysteinemia find that 1 in 4 patients developed thrombotic stroke (25%). Of course, the number of cases is too small to draw firm conclusions. Further research is needed for reliable conclusions.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mouravas, Hercules
- Μουράβας, Ηρακλής
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27013